J Biol Chem, Vol. 274, Issue 51, 36312-36320, December 17, 1999
Biosynthesis of a Neo-epi-verrucosane Diterpene in
the Liverwort Fossombronia alaskana
A RETROBIOSYNTHETIC NMR STUDY*
Wolfgang
Eisenreich
§,
Christoph
Rieder
,
Carola
Grammes¶,
Gerhard
Heßler
,
Klaus-Peter
Adam¶,
Hans
Becker¶,
Duilio
Arigoni
, and
Adelbert
Bacher
From the
Institut für Organische Chemie und
Biochemie, Technische Universität München, D-85747
Garching, Germany, ¶ Pharmakognosie und Analytische Phytochemie
der Universität des Saarlandes, D-66041 Saarbrücken,
Germany, and
Laboratorium für Organische Chemie,
Eidgenössische Technische Hochschule Zürich,
CH-8092 Zürich, Switzerland
 |
ABSTRACT |
The biosynthesis of the diterpene
8
-acetoxy-13
-hydroxy-5-oxo-13-epi-neoverrucosane in
the arctic liverwort Fossombronia alaskana was studied by
incorporation experiments using [1-13C]- and
[U-13C6]glucose as precursors. The
13C-labeling patterns of acetyl-CoA, pyruvate, and
phosphoenolpyruvate in intermediary metabolism were reconstructed from
the 13C NMR data of biosynthetic amino acids (leucine,
alanine, phenylalanine) and were used to predict hypothetical labeling
patterns for isopentenyl pyrophosphate formed via the mevalonate
pathway and the deoxyxylulose pathway. The labeling patterns observed
for the neoverrucosane diterpene were consistent with the intermediate
formation of geranyllinaloyl pyrophosphate assembled from dimethylallyl
pyrophosphate and three molecules of isopentenyl pyrophosphate
generated predominantly or entirely via 1-deoxyxylulose 5-phosphate.
The experimental data can be integrated into a detailed biosynthetic
scheme involving a 1,5-hydride shift. The postulated involvement of the
1,5-hydride shift was confirmed by an incorporation experiment with
[6,6-2H2]glucose.
 |
INTRODUCTION |
Verrucosanes are a family of tetracyclic diterpenes initially
observed in the liverworts Mylia anomala (1) and Mylia
verrucosa (2-6). More recently, verrucosane type terpenes have
also been found in other liverworts (7-14), in marine sponges (15-17)
and in the eubacterium Chloroflexus aurantiacus (18). The
structures of 5
-hydroxy-13-epi-neoverrucosane from the
liverwort Plagiochila stephensoniana (9) and of
5-oxo-13-epi-neoverrucosane from Fossombronia
alaskana (7) have been determined by x-ray structure analysis. The
major diterpene from axenic cultures of F. alaskana was
found to be
8
-acetoxy-13
-hydroxy-5-oxo-13-epi-neoverrucosane (1, Fig. 1) (7). Hypothetical
biosynthetic schemes for verrucosane-type diterpenes have been proposed
without experimental substantiation (8, 11).
In the eubacterium C. aurantiacus, the biosynthesis of
2
-hydroxyverrucosane (2) has been analyzed by in
vivo incorporation of 13C-labeled acetate samples
(19). On the basis of the observed 13C-labeling patterns,
the isoprene dissection of the diterpene has been deduced, and a
mechanism yielding the tetracyclic ring system from geranyllinaloyl
pyrophosphate (3, Fig. 2) has been proposed. Briefly, the solvolysis of the pyrophosphate moiety from
compound 3 triggers a reaction sequence via the monocyclic intermediate 4 involving a Wagner-Meerwein rearrangement (from bicyclic ionic intermediate 5 to intermediate
6), a 1,5-hydride shift (from tricyclic ionic intermediate
7 to intermediate 8), and a cyclopropyl carbinyl
to cyclopropyl carbinyl rearrangement (from intermediate 9 to intermediate 10, Fig. 2). The terpenoid building blocks,
isopentenyl pyrophosphate
(IPP,1 13, Fig.
3) and dimethylallyl pyrophosphate
(DMAPP, 14), from which compound 3 had been
assembled were derived from acetate (11) via mevalonate
(12).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 2.
Mechanism for the formation of
2 -hydroxyverrucosane (2) in C. aurantiacus as proposed by Rieder et al.
(19). Carbon atoms contributed by individual C5
monomers are boxed in compound 2.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Diversion of carbon atoms from acetyl-CoA
(11), pyruvate (15), and glyceraldehyde 3-phosphate (16) to the
isoprenoid monomers IPP (13) and DMAPP (14) by the mevalonate pathway
and the deoxyxylulose pathway. The deoxyxylulose pathway involves
a rearrangement that interrupts the contiguity of the carbon atoms
derived from triose phosphate. TPP, thiamin
pyrophosphate.
|
|
For several decades the mevalonate pathway had been assumed to be the
universal source for the building blocks of all terpenes (for review,
see Ref. 20). The existence of a second pathway was established
relatively recently on the basis of independent studies by Rohmer,
Arigoni, Sahm, and their co-workers (for review see Refs. 21 and 22).
Specifically, it was shown that the nonmevalonate pathway involved a
transketolase type condensation of glyceraldehyde 3-phosphate
(16) with "activated acetaldehyde" obtained by
decarboxylation of pyruvate (15) (Fig. 3). The first
committed intermediate of the novel pathway was shown to be
1-deoxy-D-xylulose or its 5-phosphate (17)
(23-25). An enzyme catalyzing the formation of
1-deoxy-D-xylulose 5-phosphate from glyceraldehyde
3-phosphate and pyruvate has been found recently in Escherichia
coli (26, 27) and Mentha piperita (28). A NADPH-dependent reductoisomerase catalyzing the formation
of 2-C-methylerythritol 4-phosphate (18) from
1-deoxyxylulose 5-phosphate (17) has been isolated from
E. coli (29). The reactions leading from the tetrol
phosphate (18) to IPP (13) and DMAPP (14) are still unknown.
Whereas vertebrates and archaebacteria appear to use exclusively the
mevalonate pathway for the biosynthesis of isoprenoids, different
eubacteria have been found to use either the mevalonate or
deoxyxylulose pathway (19, 30, 31). Several higher plants were found to
use predominantly the mevalonate pathway for the biosynthesis of
steroids and the deoxyxylulose pathway for the biosynthesis of
monoterpenoids, carotenoids, phytol and other diterpenes (for review,
see Ref. 21). The liverworts Conocephalum conicum and
Ricciocarpos natans have been shown to synthesize the
monoterpenes borneol and bornyl acetate as well as phytol via the
deoxyxylulose pathway, whereas the sesquiterpenes cubebanol and
ricciocarpin A, as well as stigmasterol, were derived via the
mevalonate pathway (32).
The mevalonate pathway appears to be operative in the cytoplasmic
compartment of plant cells, whereas the deoxyxylulose pathway seems to
be limited to the plastid compartment. Segregation of the two pathways,
however, is not necessarily complete, and exchange of metabolites
between the two pools has been observed in plants and plant cell
cultures (24, 25, 33-35). In retrospect, it is clear that this
cross-talk was responsible for the wide belief in a universal
mevalonate origin for all terpenoids. Due to partial metabolite
exchange between the two compartments, at least a fraction of the
mevalonate-derived building blocks was incorporated, if only in
strongly reduced yields, into those terpenoids that are now known to
originate predominantly from the deoxyxylulose pathway.
This study was initiated to elucidate the biosynthesis of the diterpene
8
-acetoxy-13
-hydroxy-5-oxo-13-epi-neoverrucosane (1, Fig. 1) in the arctic liverwort F. alaskana.
 |
EXPERIMENTAL PROCEDURES |
Chemicals--
[U-13C6]Glucose and
[1-13C]glucose were purchased from Omicron (South Bend,
IN). [6,6-2H2]Glucose was purchased from
Promochem (Wesel, Germany).
Organism--
F. alaskana STEERE & INOUE was kindly
provided by Professor Basile, New York Botanical Garden.
Culture Conditions--
Plants were cultivated in 200-ml
Erlenmeyer flasks under aseptic conditions on Gamborg B5 medium (36)
supplemented with 0.9% agar and 1% sucrose. They were kept under
continuous light at 20 °C.
Isotope Incorporation Studies--
Before experiments with
isotope-labeled glucose, plants were cultivated for at least one
culture period on the basic medium with substitution of sucrose by
glucose. The cultures were harvested after 12 weeks.
Isolation of
8
-Acetoxy-13
-hydroxy-5-oxo-13-epi-neoverrucosane
(1)--
The plant material was air-dried and pulverized (25 g,
dry weight). Percolation with diethyl ether afforded a crude extract that was fractionated by gradient vacuum liquid chromatography on
silica gel 60 (3 × 8 cm, 15 µm, 100% hexane to 100% ethyl
acetate). The fractions were checked by thin layer chromatography on
silica gel using hexane/ethyl acetate (4:1; v/v) as mobile phase.
Compound 1 (Rf, 0.15) was eluted at 55% ethyl
acetate. Fractions containing compound 1 were subjected to
gradient vacuum liquid chromatography on Lichroprep Diol (2 × 7 cm, 40-63 µm, 100% hexane to 60% ethyl acetate). Compound
1 was eluted with 35% ethyl acetate. Typically, 0.6 mg of
compound 1 was isolated/g of dry plant material.
Isolation of Amino Acids--
The hydrolysis of biomass and the
isolation of amino acids has been described earlier (37, 38).
NMR Spectroscopy--
Parameters for one- and two-dimensional
NMR experiments and quantitative analysis of 13C enrichment
as well as 13C13C coupling have been described
earlier (19). Simulation of NMR signals was performed using the NMRSIM
software package (Bruker, Germany).
Molecular Modeling--
Molecular modeling studies were
performed using the program package DISCOVER from MSI (Germany).
 |
RESULTS |
NMR Signal Assignments and Conformational Study--
To interpret
biosynthetic 13C- and 2H-labeling data, it was
mandatory to assign unequivocally all 1H and
13C NMR signals of the target molecule. 1H and
13C NMR chemical shifts of compound 1 in
CDCl3 have been reported earlier (7). A more detailed NMR
analysis was performed using HMQC, HMBC, and NOE spectroscopy
experiments (Table I). Additional
information was obtained by INADEQUATE spectroscopy of a biosynthetic
sample obtained from a feeding experiment with [U-13C6]glucose. Interproton distances were
estimated from NOE build-up rates (Table
II). The assignment of diastereotopic
protons was based on the calculated interproton distances in
conjunction with molecular modeling studies yielding the conformation
shown in Fig. 4. The assignment of the
diastereotopic methyl groups 16 (Re) and 17 (Si)
was also confirmed from the vicinal long range carbon carbon coupling
between C-12 and C-16 of 2.4 Hz, indicating a dihedral angle of
approximately 60° between these centers (39-41).
View this table:
[in this window]
[in a new window]
|
Table I
1H NMR and 13C NMR assignments of
8 -acetoxy-13 -hydroxy-5-oxo-epi-neoverrucosane
(1) in CDCl3
HMBC, heteronuclear multiple bond correlation; DQF-COSY, double
quantum-filtered COSY.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Interproton distances (in Å), calculated from NOE initial rates and
from energy minimization by molecular dynamic methods of
8 -acetoxy-13 -hydroxy-5-oxo-13-epi-neoverrucosane
|
|

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
Conformation of
8 -acetoxy-13 -hydroxy-5-oxo-13-epi-neoverrucosane.
This conformation was gleaned from the analysis of NOE effect data and
molecular dynamics calculations.
|
|
Incorporation Experiments--
F. alaskana was grown
for 12 weeks on a mineral medium solidified with agar supplemented with
isotope-labeled precursors (see below). Starting from approximately
2 g of F. alaskana cells (fresh weight), approximately
20 g of cells (dry weight) were harvested after the incorporation
period of 12 weeks. Compound 1 was extracted from the cell
mass and was purified as described under "Experimental Procedures."
Hydrolysis of biomass afforded amino acids that were isolated
chromatographically. 13C abundance and
13C13C couplings of the diterpene and amino
acids were determined by 1H and 13C NMR
spectroscopy as described earlier (19).
In the feeding experiment with
[U-13C6]glucose, the labeled precursor was
proffered together with a 10-fold excess of unlabeled glucose (culture
volume, 2 liters; unlabeled glucose, 18 g;
[U-13C6]glucose, 2 g). This feeding
strategy leads to the formation of downstream metabolites by the random
combination of metabolic intermediates derived from multiple
13C-labeled or unlabeled glucose molecules. The resulting
diterpene was therefore a complex mixture of various multiple
13C-labeled isotopomers.
The average 13C abundance of the diterpene in the
experiment with [U-13C6]glucose was 4.5%.
The ratio of 13C-labeled and unlabeled glucose in the
culture medium would have predicted an averaged enrichment of about
11%. Since the cell mass of the liverwort increased by a factor larger
than 10 during the incorporation experiment, it can be excluded that
the diterpene was significantly diluted by unlabeled material that was
already present at the beginning of the feeding experiment. Apparently, the 13C label has been diluted by photosynthetic
CO2 fixation. Analysis of 13C13C
couplings in the one-dimensional 13C NMR spectrum and in
two-dimensional 13C INADEQUATE experiments (Table I)
indicated that seven pairs of carbon atoms were incorporated jointly
from the glucose precursor into the ring system of the diterpene (Fig.
5A). Moreover, the acetyl
moiety at carbon atom eight showed the presence of a double-labeled acetate isotopomer.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5.
13C-Labeling patterns of
8 -acetoxy-13 -hydroxy-5- oxo-13-epi-neoverrucosane
(1). A, from the experiment with
[U-13C6]glucose; pairs of adjacent
13C atoms are shown by bold lines, and multiple
13C couplings are shown by arrows; B,
from the experiment with [1-13C]glucose; the
numbers indicate 13C abundance in %;
C, dissection of isoprenoid monomers; carbon atoms
contributed by individual C5 monomers are
boxed.
|
|
In addition to one-bond 13C13C couplings,
several 13C13C couplings via two or three bonds
(indicated by arrows in Fig. 5A) were observed in the
13C NMR spectrum and in a two-dimensional INADEQUATE
experiment optimized for magnetization transfer via small coupling constants.
In the experiment with [1-13C]glucose (culture volume, 1 liter; unlabeled glucose, 5 g; [1-13C]glucose,
5 g), nine 13C signals of compound 1 (carbon atoms 2, 6, 9, 12, 17, 18, 19, 20, and 22) displayed increased
intensities (Fig. 5B). By comparison with the spectra of the
unlabeled diterpene, an average 13C content of 9.3 ± 0.2% was determined for these centers. A 13C content of
4.0 ± 0.3% was found for the other carbon atoms of the
diterpene, reflecting significant reshuffling of
[1-13C]glucose during the growth period of 12 weeks.
The C5 building blocks contributed by the isoprenoid
precursors IPP and DMAPP were assigned on the basis of the observed
labeling patterns (Fig. 5C). It is immediately obvious that
one C5 moiety (comprising C-9, C-10, C-11, C-14, and C-20
of the diterpene) must have undergone reshuffling of the original
isoprenoid precursor via at least one rearrangement reaction. On the
other hand, three isoprenoid units have retained the connectivity
present in the precursor.
The arrangement of the C5 building blocks in the
neoverrucosane system (Fig. 5C) was similar to that in
2
-hydroxyverrucosane (Fig. 2) formed by the eubacterium C. aurantiacus and a mechanism for the formation of the
neoverrucosane skeleton from geranyllinaloyl pyrophosphate can be
adapted from the one proposed earlier for the 2
-hydroxyverrucosane
cyclase (19) (see "Discussion").
Biogenetic Origin of the C5 Building Blocks--
The
formation of isoprenoid C5 units, IPP and DMAPP, starts
from acetyl-CoA in case of the mevalonate pathway and from pyruvate and
glyceraldehyde 3-phosphate in case of the deoxyxylulose pathway (Fig.
3). The labeling patterns of acetyl CoA, pyruvate, and glyceraldehyde 3-phosphate are difficult to determine directly because these central
intermediates represent only trace amounts of total biomass. However,
their labeling patterns can be reconstructed tentatively by
retrobiosynthetic analysis from the labeling patterns of amino acids
(42). For this purpose, we hydrolyzed the residual cell mass after
verrucosane isolation and isolated amino acids from the hydrolysate by
ion exchange chromatography and high performance liquid chromatography.
Specifically, the carboxylic atom and the
carbon atom of leucine
are derived from acetyl CoA via condensation with
-ketoisovalerate.
The labeling pattern of C-1 and C-2 of leucine, therefore, can be taken
as a reference for the labeling pattern of acetyl-CoA. Indeed, the
validity of this method is vindicated by comparison with the observed
labeling pattern of the acetyl moiety of the diterpene. The labeling
pattern of acetyl CoA (11, as reconstructed from leucine,
Figs. 6C,
7C) and the labeling pattern
of the acetyl moiety of the verrucosane diterpene (Figs. 6A,
7A) were in close correspondence. Alanine is
biosynthetically obtained by reductive amination of pyruvate. Hence,
the labeling pattern of pyruvate can be reconstructed from that of
alanine. The labeling pattern of glyceraldehyde 3-phosphate cannot be
easily determined directly; however, it can be expected to be similar to that of phosphoenolpyruvate, which is obtained from labeling patterns of the side chains of phenylalanine and tyrosine. The reconstructed labeling patterns of acetyl CoA (11), pyruvate (15) and glyceraldehyde 3-phosphate/phosphoenolpyruvate (16) from the incorporation experiments with
[U-13C6]glucose and
[1-13C]glucose are summarized in Figs. 6 and 7,
respectively.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Observed and predicted labeling patterns of
8 -acetoxy-13 -hydroxy-5-oxo-13-epi-neoverrucosane
(1) and 13C NMR signals of C-12 (indicated by an
arrow) after feeding of
[U-13C6]glucose diluted with unlabeled
glucose (1:9; w/w) to a culture of F. alaskana.
The arabic numbers indicate 13C
abundance of individual carbon atoms; the bold lines
indicate isotopomers with adjacent 13C atoms; the
arrows indicate isotopomers involving long range
13C13C couplings; the italic numbers
indicate fractions of 13C13C-coupled satellite
signals in the global 13C NMR signal intensities.
A, observed isotopomer pattern in the diterpene; the
isotopomer pattern of IPP (13) was reconstructed from the
isoprene dissection of the diterpene (see Fig. 5C).
B, prediction via the deoxyxylulose pathway on the basis of
the labeling patterns of pyruvate (15) and glyceraldehyde
3-phosphate (16) reconstructed from the observed labeling
patterns of alanine and tyrosine, respectively; C,
prediction via the mevalonate pathway on the basis of the labeling
pattern of acetyl CoA (11) reconstructed from the observed
labeling pattern of leucine.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Observed and predicted labeling patterns of
8 -acetoxy-13 -hydroxy-5-oxo-13-epi-neoverrucosane
after feeding of [1-13C]glucose. The
numbers indicate 13C abundance in %. The
dotted atoms indicate high 13C enrichment from
[1-13C]glucose; for details see also legend to Fig. 6.
A, observed; the isotopomer pattern of IPP (13)
was reconstructed from the observed labeling pattern in the diterpene.
B, prediction via the deoxyxylulose pathway; C,
prediction via the mevalonate pathway.
|
|
As in previous studies (19, 42), hypothetical labeling patterns for IPP
(13) were predicted on the basis of reconstructed labeling
patterns of the building blocks, acetyl-CoA in the mevalonate route
(Figs. 6C and 7C) and pyruvate/glyceraldehyde
3-phosphate in the deoxyxylulose route (Figs. 6B and
7B), respectively. Figs. 6A and 7A
show the observed labeling pattern of the diterpene and the
reconstruction of the IPP precursor based on the isoprenoid dissection
(see Fig. 5C) by averaging of the enrichment data over the
three isoprenoid units, which have conserved their connectivities in
the cyclization process. The comparison of the experimentally determined labeling pattern with the hypothetical predictions shows
unequivocally that the DMAPP and the three IPP moieties used as
building blocks of the diterpene were generated predominantly, if not
entirely, via the deoxyxylulose pathway. This conclusion was confirmed
by simulation of 13C NMR signals based on the predicted
isotopomer compositions in the diterpene. As shown for the
13C NMR signal of C-12, the signal simulated from the
deoxyxylulose prediction was in close correspondence to the observed
13C NMR signal, whereas the predicted signal from the
mevalonate hypothesis was clearly at odds (Fig. 6).
Evidence for a 1,5-Hydride Shift in Verrucosane Formation--
The
mechanism proposed for the formation of the verrucosane system in
C. aurantiacus (19) postulates a 1,5-hydride shift from
position 2 to position 15 of intermediate 7 (Fig. 2). To
check the validity of this hypothesis in the biosynthesis of compound
1, we decided to use a strategy leading to in
vivo deuteration of C-2 in intermediate 7a (Fig.
8). According to the isoprene dissection
shown in Fig. 5C and the 1-deoxyxylulose 5-phosphate origin
of the C5 building blocks, C-2 in the ionic intermediate,
7a is derived from C-1 of IPP and ultimately from C-3 of
glyceraldehyde 3-phosphate. A feeding experiment was performed with
[6,6-2H2]glucose (culture volume, 1 liter;
[6,6-2H2]glucose, 10 g), which is
expected to afford [3,3-2H2] glyceraldehyde
3-phosphate next to [3,3-2H2]pyruvate by
glycolysis (Fig. 8).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 8.
2H isotopomer composition of
8 -acetoxy-13 -hydroxy-5-oxo-13-epi-neoverrucosane
(1) after feeding of [6,6-2H2]glucose.
Carbon atoms contributed by individual C5 monomers are
boxed (see also Fig. 5C). The numbers in
italics indicate 2H enrichments in % calculated
from - and -shifted satellite signals in the 13C NMR
spectrum. The 2H distribution in the precursors were
adjusted to accommodate the observed labeling pattern in compound
1.
|
|
The 2H NMR spectrum of the resulting compound 1 was complex (Fig. 9B), and the
deuterium substitution pattern in compound 1 was therefore
determined in the 1H,2H-decoupled
13C spectrum analyzing satellite lines caused by
2H isotope shifts. As an example, the 13C
signatures of carbon atoms 16 and 17 are shown in Fig.
10B. C-16 and C-17 displayed
satellite signals characterized by up-field shifts of 106 and 111 ppb,
respectively. Both satellite lines could be attributed unequivocally to
compound 1 via a two-dimensional 2H-decoupled
13C1H-COSY experiment (Fig. 10A)
showing that the unshifted 13C signals as well as the
up-field-shifted satellites display correlations to the same
1H signals of the diterpene. As expected, the cross-peaks
of the up-field 13C satellites showed a slight up-field
shift of the protons, sensing the presence of an adjacent
2H atom. The size of the up-field shift in the
13C NMR signals for C-16 and C-17 was typical for a
2H isotope effect via two bonds, thus indicating that the
adjacent methine group 15 carried a deuterium atom. The complete
breakdown of 2H distribution in compound 1 obtained from the detailed quantitative analysis of
and
shifts
in the 13C NMR spectrum (Table
III) is summarized in Fig. 8. In
addition, the data confirm the presence of deuterium at positions
originating from C-1 of IPP (21.3 ± 2.3% 2H) and
from C-5 of IPP (5.3 ± 1.8% 2H). The low
2H enrichment values in the methyl groups derived from C-5
of IPP are explained by deuterium loss via keto-enol tautomerization of
pyruvate. A similar 2H distribution pattern has been
observed earlier in deoxyxylulose-derived IPP in an incorporation
experiment with Ginkgo biloba using
[6,6-2H2]glucose as a precursor (24).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 9.
Parts of 1H and 2H
NMR spectra of
8 -acetoxy-13 -hydroxy-5-oxo-13-epi-neoverrucosane
(1) after feeding of [6,6-2H2]glucose.
A, simulated 2H NMR spectrum on the basis of the
2H isotopomer composition deduced from the
13C(1H,2H) NMR experiment;
B, observed 2H NMR spectrum; C,
observed 1H NMR spectrum.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 10.
NMR signals of
8 -acetoxy-13 -hydroxy-5-oxo-epi-neoverrucosane
after feeding of [6,6-2H2]glucose.
A, signals from a two-dimensional
13C1H-COSY experiment; B,
1H,2H-decoupled 13C NMR
signals.
|
|
View this table:
[in this window]
[in a new window]
|
Table III
2H isotope effects on 13C NMR frequencies in
8 -acetoxy-13 -hydroxy-5-oxo-epi-neoverrucosane
(1) after feeding with
[6,6-2H2]glucose
The position of deuteration in compound 1 conducive to a
shifted satellite of the respective index 13C NMR signal is
indicated in parenthesis.
|
|
 |
DISCUSSION |
On the basis of incorporation studies using radioactively labeled
mevalonate or acetate and despite low incorporation yields, the
biosynthesis of numerous plant terpenoids has been taken to rest
entirely on the operation of the mevalonate pathway. Even in those
cases where the expected location of the expected label was
subsequently verified by painstaking degradation procedures, it is
nowadays clear that the observed results do not constitute proof for
the exclusive operation of the expected pathway. More recent studies
have shown that metabolite exchange between mevalonate- and
deoxyxylulose-derived terpenoid building blocks (IPP or others) is
occurring in plants.
Thus, in seedlings of G. biloba, deoxyxylulose-derived
precursors were found to contribute 0.5% of steroids supposed to
be biosynthesized via the mevalonate pathway in the cytosolic
compartment of the cell (24). Involvement of both IPP biosynthetic
pathways has also been reported in cell cultures of Catharanthus
roseus (33) and in Matricaria recutitas (34), as well
as for the formation of terpenoids in some Actinomycetes (43, 44).
Recently, a variety of plant terpenoids have been reported to be formed
via the deoxyxylulose route on the basis of incorporation experiments
with 1-deoxy-D-xylulose (33, 35, 45-48). Clearly, these
experiments must be interpreted with the same qualifications as the
earlier experiments with mevalonate. Unless the incorporation rates of
1-deoxy-D-xylulose are very high, it remains open whether the compound is diverted to a specific terpenoid via the major route or
via cross-talk of this major route with the other pathway. This
question can be solved only by consideration of the quantitative aspects of metabolite flux within the organism under investigation. Flux parameters can be investigated by quantitative NMR analysis using
general 13C-labeled precursors (glucose, acetate) in
conjunction with the retrobiosynthesis concept (for review, see Ref.
42). The comparative analysis of isotopomer patterns in terpenoids and
amino acids after incorporation of various 13C-labeled
glucoses was used in this study to analyze the origin of a
neoverrucosane-type diterpene in the arctic liverwort, F. alaskana.
The data show conclusively that the C5 building blocks IPP
and DMAPP of the neoverrucosane are biosynthesized predominantly (>95%) via the deoxyxylulose pathway. In contrast, earlier studies with the eubacterium C. aurantiacus have shown that the
isoprenoid building blocks of the structurally related
2
-hydroxyverrucosane are derived from the mevalonate pathway
(19).
In addition, the labeling patterns observed in compound 1 cast light on the mechanisms responsible for the formation of the
13-epi-neoverrucosane ring system. More specifically, the labeling data were consistent with the formation of the neoverrucosane system from geranyllinaloyl pyrophosphate (3) via the
proposed intermediate 6 of bacterial verrucosane
biosynthesis (Fig. 2). With the appropriate conformation of the side
chain (see below), attack of the cationic center in intermediate
6 on the isopropylidene double bond leads to the tricyclic
ion 7a with "epi-configuration" at carbon
atom 13 (Fig. 11). As proposed earlier
for the biosynthesis of 2
-hydroxyverrucosane, a 1,5-hydride transfer
from the C-2 methylene group generates the homoallylic intermediate
8a, which collapses to the cyclopropylcarbinyl ion
9a. Saturation of the positive charge in intermediate 9a by the addition of a hydroxyl group from the solvent then
yields 5
-hydroxy-13-epi-neoverrucosane (19),
which is known as a natural product from cultures of F. alaskana (7). The formation of compound 1 is then
completed by hydroxylations of compound 19 at C-13 and C-8,
acetylation of the hydroxyl group at position 8, and oxidation of the
hydroxyl group at position 5.
In the case of the verrucosane system, a boat conformation for the
chain segment of precursor 6 involved in the formation of
the five-membered ring was implied by the trans-arrangement of the
hydrogen atoms at C-14 and C-13 and shown to be responsible for the
observed stereospecific labeling of the diastereotopic methyl group
C-17 in the isopropyl chain of compound 2 from the methyl
group of mevalonate (the Re-methyl group of compound 2 corresponding to the Z-methyl group of the aliphatic precursor) (19). In contrast to this result, the experimental data
disclose that in the case of compound 1 it is the Si-methyl group (responsible for the signal at 19.92 ppm in
the 13C NMR spectrum) that maintains its bond-labeling to
the adjacent C-15 in the experiment with
[U-13C6]glucose and that is specifically
enriched from [1-13C]glucose and therefore corresponds to
the Z-methyl group of the aliphatic precursor. This "inverse" label
distribution is compatible only with a prechair conformation of the
cyclizing chain segment in intermediate 6a, resulting in the
formation of a tetracyclic intermediate 7a with a cis
arrangement of the hydrogen atoms of C-14 and C-13 (Fig.
12). It follows that the subsequent hydroxylation at C-13 is indeed occurring as expected with retention of
configuration.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 12.
Stereochemical course of the five-membered
ring formation for
8 -acetoxy-13 -hydroxy-5-oxo-13-epi-neoverrucosane
(1) in F. alaskana (left) and for
2 -hydroxyverrucosane (2) in C. aurantiacus (right). The
dotted methyl groups indicate biosynthetic origin from the
methyl group of 1-deoxyxylulose (Fossombronia) and the
methyl group of mevalonate (Chloroflexus).
|
|
Evidence for an unusual 1,5-hydride shift before formation of the
cyclopropyl moiety in compound 1 was obtained by an
incorporation experiment with
[6,6-2H2]glucose, confirming the earlier
proposal for 2
-hydroxyverrucosane cyclases (19). The content of
2H at C-15 (12.3%) was perfectly in line with its origin
by transfer from a center derived from one of the hydrogen atoms of C-1
of the IPP precursor (10.7 ± 1.2% 2H). To
double-check the 2H substitution pattern deduced from the
13C spectrum, the 2H NMR spectrum was simulated
(Fig. 9A). For that purpose, 2H signals were
modeled as Gaussian line shapes with a line width of 5 Hz, and
intensities of individual lines were taken from Fig. 8. The simulated
spectrum is similar to the experimental 2H NMR spectrum
(Fig. 9B). The peak at 2.30 ppm in the experimental 2H spectrum thus confirms the presence of deuterium at
C-15. In summary, the data provide firm evidence that a deuteride ion
was transferred from C-2 to the positively charged center located at
C-15 in intermediate 7a. This experimental finding rules out
the validity of a previous proposal (8) in which generation of
intermediate 8a from intermediate 7a was
suggested to imply four successive 1,2-hydride shifts.
The data presented in this study demonstrate again that the
quantitative analysis of 13C- and 2H-labeling
patterns from universal precursors (i.e.
[13C]glucose, [2H]glucose) in conjunction
with the retrobiosynthesis concept (42) is a powerful tool for
metabolite flux analysis. Even in the complex biological system used in
this study (i.e. liverwort growing for 3 months on agar
supplemented with the isotope-labeled glucoses), the building blocks of
a specific biosynthetic pathway are clearly discernable.
 |
FOOTNOTES |
*
This work was supported by Deutsche Forschungsgemeinschaft
Grant SFB 369 and a grant from the Fonds der Chemischen Industrie.
§
To whom correspondence should be addressed: Lehrstuhl für
Organische Chemie und Biochemie, Technische Universität
München, Lichtenbergstr. 4, D-85747 Garching, Germany. Tel.:
49-89-289-13043; Fax: 49-89-289-13363; E-mail:
wolfgang.eisenreich@ch.tum.de.
 |
ABBREVIATIONS |
The abbreviations used are:
IPP, isopentenyl
pyrophosphate;
DMAPP, dimethylallyl pyrophosphate;
NOE, nuclear
Overhauser effect.
 |
REFERENCES |
| 1.
|
Benesova, V.,
Benes, I.,
Chan, H.,
and Herout, V.
(1975)
Collect. Czech. Chem. Commun.
40,
658-661
|
| 2.
| Hayashi, S., Matsuo, A., Nozaki, A., Nakayama, M., Takaoka, D., and
Hiroi, M. (1978) Chem. Lett. 953-956
|
| 3.
| Matsuo, A., Nozaki, H., Nakayama, M., Hayashi, S., and Takaoka, D. (1978) J. Chem. Soc. Chem. Commun. 198-200
|
| 4.
| Nozaki, H., Matsuo, A., Kushi, Y., Nakayama, M., Hayashi, S., Takaoka,
D., and Kamijo, N. (1980) J. Chem. Soc. Perkin Trans.
II 763-767
|
| 5.
| Takaoka, D. (1979) J. Chem. Soc. Perkin Trans. II
2711-2718
|
| 6.
|
Takaoka, D.,
Matsuo, A.,
Nakayama, N.,
and Hayashi, S.
(1983)
Phytochemistry
22,
1653-1655[CrossRef]
|
| 7.
|
Grammes, C.,
Burkhardt, G.,
Veith, M.,
Huch, V.,
and Becker, H.
(1997)
Phytochemistry
44,
1495-1502[CrossRef]
|
| 8.
|
Toyota, M.,
Nakaishi, E.,
and Asakawa, Y.
(1996)
Phytochemistry
43,
1057-1064[CrossRef]
|
| 9.
|
Fukuyama, Y.,
Masuya, T.,
Tori, M.,
Kido, M.,
Wakamatsu, M.,
and Asakawa, Y.
(1988)
Phytochemistry
27,
1797-1799[CrossRef]
|
| 10.
|
Kubo, I.,
Matsumoto, A.,
Hirotsu, K.,
Naoki, H.,
and Wood, W. F.
(1984)
J. Org. Chem.
49,
4644-4646[CrossRef]
|
| 11.
|
Matsuo, A.,
Atsumi, K.,
and Nakayama, M.
(1984)
Z. Naturforsch.
39,
1281-1285
|
| 12.
|
Hashimoto, T.,
Nakamura, I.,
Tori, M.,
Takaoka, S.,
and Asakawa, Y.
(1995)
Phytochemistry
38,
119-127
|
| 13.
|
Asakawa, Y.,
Masuya, T.,
Tori, M.,
and Fukuyama, Y.
(1988)
Phytochemistry
27,
3509-3511[CrossRef]
|
| 14.
|
Wu, C.-L.,
and Chang, S.-J.
(1988)
J. Hattori Bot. Lab.
64,
151
|
| 15.
| Nakamura, H., To, S., Takamatsu, M., Kobayashi, J., Ohizumi, Y., Kondo,
K., and Hirata, Y. (1990) in Symposium Papers of 59th Annual
Meeting of Chemical Society of Japan, p. 1197, Japan
|
| 16.
|
Compagnone, R. S.,
and Faulkner, D. J.
(1995)
J. Nat. Prod. (Lloydia)
58,
145-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
| Tanaka, J., Nurrachmi, I., and Higa, T. (1997) Chem. Lett.
489-490
|
| 18.
|
Hefter, J.,
Richnow, H. H.,
Fischer, U.,
Trendel, J. M.,
and Michaelis, W.
(1993)
J. Gen. Microbiol.
139,
2757-2761
|
| 19.
|
Rieder, C.,
Strauß, G.,
Fuchs, G.,
Arigoni, D.,
Bacher, A.,
and Eisenreich, W.
(1998)
J. Biol. Chem.
273,
18099-18108[Abstract/Free Full Text]
|
| 20.
|
Qureshi, N.,
and Porter, J. W.
(1981)
in
Biosynthesis of Isoprenoid Compounds
(Porter, J. W.
, and Spurgeon, S. L., eds), Vol. I
, pp. 47-94, John Wiley & Sons, Inc., New York
|
| 21.
|
Eisenreich, W.,
Schwarz, M.,
Cartayrade, A.,
Arigoni, D.,
Zenk, M. H.,
and Bacher, A.
(1998)
Chem. Biol. (Lond.)
5,
221-233
|
| 22.
| Rohmer, M. (1998) Prog. Drug Res. 135-154
|
| 23.
|
Broers, S. T. J.
(1994)
On the Early Stages of Isoprenoid Biosynthesis in E. coli.Ph.D. thesis
, Eidgenössische Technische Hochschule Zürich
|
| 24.
|
Schwarz, M. K.
(1994)
Terpene Biosynthesis in Ginkgo biloba: A Surprising StoryPh.D. thesis
, Eidgenössische Technische Hochschule Zürich
|
| 25.
|
Cartayrade, A.,
Schwarz, M.,
Jaun, B.,
and Arigoni, D.
(1994)
2nd Symposium of the European Network on Plant Terpenoids January 23-27, Abstract P1
, Strasbourg/Bischenberg, Germany
|
| 26.
|
Sprenger, G. A.,
Schörken, U.,
Wiegert, T.,
Grolle, S.,
de Graaf, A. A.,
Taylor, S. V.,
Begley, T. P.,
Bringer-Meyer, S.,
and Sahm, H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12857-12862[Abstract/Free Full Text]
|
| 27.
|
Lois, L. M.,
Campos, N.,
Putra, S. R.,
Danielsen, K.,
Rohmer, M.,
and Boronat, A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2105-2110[Abstract/Free Full Text]
|
| 28.
|
Lange, B. M.,
Wildung, M. R.,
McCaskill, D.,
and Croteau, R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2100-2104[Abstract/Free Full Text]
|
| 29.
|
Takahashi, S.,
Kuzuyama, T.,
Watanabe, H.,
and Seto, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9879-9884[Abstract/Free Full Text]
|
| 30.
|
Horbach, S.,
Sahm, H.,
and Welle, H.
(1993)
FEMS Microbiol. Lett.
111,
135-140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Putra, S. R.,
Lois, L. M.,
Campos, N.,
Boronat, A.,
and Rohmer, M.
(1998)
Tetrahedron Lett.
39,
23-26
|
| 32.
|
Adam, K. P.,
Thiel, R.,
Zapp, J.,
and Becker, H.
(1998)
Arch. Biochem. Biophys.
354,
181-187[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Arigoni, D.,
Sagner, S.,
Latzel, C.,
Eisenreich, W.,
Bacher, A.,
and Zenk, M. H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
10600-10605[Abstract/Free Full Text]
|
| 34.
|
Adam, K. P.,
and Zapp, J.
(1998)
Phytochemistry
48,
953-959[CrossRef]
|
| 35.
|
Piel, J.,
Donath, J.,
Bandemer, K.,
and Boland, W.
(1998)
Angew. Chem. Int. Ed. Engl.
37,
2478-2481[CrossRef]
|
| 36.
|
Gamborg, O. L.,
Miller, R. A.,
and Ojima, K.
(1968)
Exp. Cell Res.
50,
151-158[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Eisenreich, W.,
Schwarzkopf, B.,
and Bacher, A.
(1991)
J. Biol. Chem.
266,
9622-9631[Abstract/Free Full Text]
|
| 38.
|
Eisenreich, W.,
Strauß, G.,
Werz, U.,
Fuchs, G.,
and Bacher, A.
(1993)
Eur. J. Biochem.
215,
619-632[Medline]
[Order article via Infotrieve]
|
| 39.
|
Barfield, M.,
Burfitt, T.,
and Doddrell, D.
(1975)
J. Am. Chem. Soc.
97,
2631-2634[CrossRef]
|
| 40.
|
Barfield, M.,
Canada, E. D., Jr.,
McDaniel, C. R., Jr.,
Marshall, J. L.,
and Walter, S. R.
(1983)
J. Am. Chem. Soc.
105,
3411-3417[CrossRef]
|
| 41.
|
Doddrell, D.,
Burfitt, I.,
Grutzner, J. B.,
and Barfield, M.
(1974)
J. Am. Chem. Soc.
96,
1241-1243[CrossRef]
|
| 42.
|
Bacher, A.,
Rieder, C.,
Eichinger, D.,
Fuchs, G.,
and Eisenreich, W.
(1998)
FEMS Microbiol. Rev.
22,
567-598
|
| 43.
|
Seto, H.,
Watanabe, H.,
and Furihata, K.
(1996)
Tetrahedron Lett.
37,
7979-7982[CrossRef]
|
| 44.
|
Seto, H.,
Orihara, N.,
and Furihata, K.
(1998)
Tetrahedron Lett.
39,
9497-9500[CrossRef]
|
| 45.
|
Schwender, J.,
Zeidler, J.,
Gröner, R.,
Müller, C.,
Focke, M.,
Braun, S.,
Lichtenthaler, F. W.,
and Lichtenthaler, H. K.
(1997)
FEBS Lett.
414,
129-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Zeidler, J. G.,
Lichtenthaler, H. K.,
May, H. V.,
and Lichtenthaler, F. W.
(1997)
Z. Naturforsch.
52,
15-23
|
| 47.
|
Sagner, S.,
Eisenreich, W.,
Fellermeier, M.,
Latzel, C.,
Bacher, A.,
and Zenk, M. H.
(1998)
Tetrahedron Lett.
39,
2091-2094[CrossRef]
|
| 48.
| Sagner, S., Latzel, C., Eisenreich, W., Bacher, A., and Zenk, M. H. (1998) J. Chem. Soc. Chem. Commun.,
221-222
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.